Skip to main content
. 2015 May 28;7(9):1251–1257. doi: 10.4254/wjh.v7.i9.1251

Figure 1.

Figure 1

Pathogenic mechanisms of valproic acid-induced nonalcoholic fatty liver disease/nonalcoholic steato-hepatitis. VPA: Valproic acid; GABA: Gamma-aminobutyric acid; FIAF: Fasting-induced adipose factor; ADIPO-R1: Adiponectin receptor expression; NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic steato-hepatitis.